SC 13G
SABBY 13G RNN 2.29.16
- Company
- Opus Genetics, Inc.
- Filed
- February 29, 2016
- Accession Number
- 0001535610-16-000141
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →